TNF-alpha is critical for antitumor but not antiviral T cell immunity in mice.
about
Direct crosstalk between mast cell-TNF and TNFR1-expressing endothelia mediates local tissue inflammation.MicroRNA-150 modulates intracellular Ca 2+ levels in naïve CD8+ T cells by targeting TMEM20.Maturation-dependent licensing of naive T cells for rapid TNF production.Identification of Lactobacillus strains with probiotic features from the bottlenose dolphin (Tursiops truncatus)The effect of feeding mice during gestation and nursing with Rhodiola kirilowii extracts or epigallocatechin on CD4 and CD8 cells number and distribution in the spleen of their progenyThe histone deacetylase inhibitor, LBH589, promotes the systemic cytokine and effector responses of adoptively transferred CD8+ T cellsAdoptive immunotherapy with Cl-IB-MECA-treated CD8+ T cells reduces melanoma growth in miceEndogenous T cell responses to antigens expressed in lung adenocarcinomas delay malignant tumor progression.Intrinsic TNF/TNFR2 interactions fine-tune the CD8 T cell response to respiratory influenza virus infection in mice.Effects of reticuloendotheliosis virus infection on cytokine production in SPF chickens.Peptide-pulsed dendritic cells have superior ability to induce immune-mediated tissue destruction compared to peptide with adjuvantContrasting effects of TNF and anti-TNF on the activation of effector T cells and regulatory T cells in autoimmunity.Effective colon cancer prophylaxis in mice using embryonic stem cells and carbon nanotubesTransgenic 4-1BBL-engineered vaccine stimulates potent Gag-specific therapeutic and long-term immunity via increased priming of CD44(+)CD62L(high) IL-7R(+) CTLs with up- and downregulation of anti- and pro-apoptosis genes.Cholesteryl Pullulan Encapsulated TNF-α Nanoparticles Are an Effective Mucosal Vaccine Adjuvant against Influenza VirusRACK1 antagonizes TNF-α-induced cell death by promoting p38 activation.Cellular and molecular immunology of lung cancer: therapeutic implications.Phenotypic screening reveals TNFR2 as a promising target for cancer immunotherapy.TNF signaling drives myeloid-derived suppressor cell accumulation.Epithelial derived CTGF promotes breast tumor progression via inducing EMT and collagen I fibers deposition.CD4 T cells, lymphopenia, and IL-7 in a multistep pathway to autoimmunity.Effective tumor treatment targeting a melanoma/melanocyte-associated antigen triggers severe ocular autoimmunityA phase I dose escalation study of Ad GV.EGR.TNF.11D (TNFerade™ Biologic) with concurrent chemoradiotherapy in patients with recurrent head and neck cancer undergoing reirradiation.Inflammation-Dependent IL18 Signaling Restricts Hepatocellular Carcinoma Growth by Enhancing the Accumulation and Activity of Tumor-Infiltrating Lymphocytes.The TNF Receptor Superfamily in Co-stimulating and Co-inhibitory ResponsesTumor necrosis factor and cancer, buddies or foes?Evaluation of innate and adaptive immunity contributing to the antitumor effects of PD1 blockade in an orthotopic murine model of pancreatic cancerEnhancing the safety of antibody-based immunomodulatory cancer therapy without compromising therapeutic benefit: Can we have our cake and eat it too?TNF-alpha is a positive regulatory factor for human Vgamma2 Vdelta2 T cells.TNFR2 expression by CD4 effector T cells is required to induce full-fledged experimental colitisSTIM1 and STIM2-mediated Ca(2+) influx regulates antitumour immunity by CD8(+) T cellsAging predisposes to acute inflammatory induced pathology after tumor immunotherapy.The tumor-promoting actions of TNF-alpha involve TNFR1 and IL-17 in ovarian cancer in mice and humans.Autologous CIK cell immunotherapy in patients with renal cell carcinoma after radical nephrectomy.Tumor necrosis factor-α/CD40 ligand-engineered mesenchymal stem cells greatly enhanced the antitumor immune response and lifespan in mice.Clinical utility of etanercept in the treatment of arthritides in children and adolescents.TNF activity and T cells.Etanercept, improved dosage schedules and combinations in the treatment of psoriasis: an update.Enhanced Requirement for TNFR2 in Graft Rejection Mediated by Low-Affinity Memory CD8+ T Cells during Heterologous Immunity.Membrane tumor necrosis factor (TNF) induces p100 processing via TNF receptor-2 (TNFR2).
P2860
Q30489747-5EF63D33-8039-49A6-A3A7-B398984130E7Q33752767-812E619A-431C-4F55-8828-68CD37D98F87Q33760914-EE185FB0-9606-43B8-92B4-11DB9FB589A5Q33777194-993A4D08-86D3-46E4-A5B5-F6339D0CE81FQ33797124-0B32CB1F-E2C9-4F31-A2FA-4BB3B9D0912BQ33928765-94D56F53-3F7F-4183-9F08-3989810ADADAQ34428963-55B82E44-ADE6-4FF4-B974-E852824B3CDFQ34755544-888F3ED5-1091-4C2D-82E7-CE46C78BFEE5Q34851737-04907C59-8202-41BF-AA7C-4321FBE76397Q35073202-E69DAEBB-05BB-4DA1-A9DE-4FF0D0C1B5A8Q35125382-348062A3-2C37-4F9E-86F3-BCBB50AA74A4Q35190025-4E66F2D5-3DF3-48A3-8640-B3AAA707456AQ35234708-FEBFC3CB-DD1D-4DBB-8672-F262FED9ADD3Q35833636-CA2795E4-688B-457D-9571-51CEAA700B58Q36059495-1FEDC7CE-7E41-4338-BF94-73E27CB5ADCFQ36098877-B25321C4-F7D4-4600-95BF-1F36F79FC0D8Q36130505-8F879FAF-385E-4C52-A4A5-6BA8E8E09321Q36132344-F10636D8-9FBC-49CD-A6F4-01C029699B38Q36357903-BE0C660B-2695-4FBD-ACC2-24CE4EC1C726Q36413175-DBE6894A-973C-47AF-9A66-32EC8133E6A3Q36498454-045BDE88-A07A-43AF-9EEB-67FA230A02E4Q36693023-A542EE84-B64E-430C-B8E0-CE46995547EAQ36870401-61D558C5-D203-483B-87BB-54BD966E5DFEQ36918035-D8FD400F-C750-4E48-A407-108A7E7151DBQ36940326-57516E4B-3B4D-430B-8CFC-1464D2F1DC05Q37073092-8F432921-6D22-4BD9-92DC-A802E64C9E05Q37079133-0CBD70F9-3D03-4479-9CEF-369F484AF6FAQ37114367-D4E331A4-2F17-4263-842C-82BE548BBAF2Q37120229-D394DDC7-2066-482F-82CE-583BD63A3426Q37236581-844DFE9A-D39E-4966-BBA5-EA6851D922DFQ37236886-E14C803E-CD9B-483C-B5A3-53EE1F95A00BQ37246492-B48EFACB-E6DF-46EB-A70A-57F31BCFE9F6Q37363065-4822D1B3-EA0C-4303-AC01-A63334D5819EQ37412513-985EBE0E-FCE6-4E99-AB73-A8A571659D14Q37640522-60DE9129-69A9-4BAC-BE4A-FB8A04D5B3D2Q37676020-4DCD90AD-0EB5-49F9-8F4E-521DC4408449Q38929182-6A1CC1CA-6920-4FCA-A0D5-0BDC4E7EDA25Q39180810-4FE715BA-31E0-409E-8737-B2489A941101Q39535048-CF93C590-8F01-498A-84C3-DCCBFFD21BD0Q39758262-A267E5C8-3DEC-4CC0-A44E-525A6F900668
P2860
TNF-alpha is critical for antitumor but not antiviral T cell immunity in mice.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
TNF-alpha is critical for antitumor but not antiviral T cell immunity in mice.
@ast
TNF-alpha is critical for antitumor but not antiviral T cell immunity in mice.
@en
type
label
TNF-alpha is critical for antitumor but not antiviral T cell immunity in mice.
@ast
TNF-alpha is critical for antitumor but not antiviral T cell immunity in mice.
@en
prefLabel
TNF-alpha is critical for antitumor but not antiviral T cell immunity in mice.
@ast
TNF-alpha is critical for antitumor but not antiviral T cell immunity in mice.
@en
P2093
P2860
P50
P356
P1476
TNF-alpha is critical for antitumor but not antiviral T cell immunity in mice.
@en
P2093
Alisha R Elford
Håkan Hall
Nobuyuki Ono
P2860
P304
P356
10.1172/JCI32567
P407
P577
2007-12-01T00:00:00Z